Investor Relations

Cassava Sciences, Inc. is a biopharmaceutical company that develops novel drugs.

Presentations

Financial Information

Press Releases

Cassava Sciences to Present at Maxim Group’s Conference on Alzheimer’s Disease

Jun 18, 2019

AUSTIN, Texas , June 18, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA ), a clinical-stage biotechnology company, announced today that Remi Barbier , its President and CEO, will present at Maxim Group’s conference on Alzheimer’s disease on Wednesday, June 26 th , in New York. 

Cassava Sciences Announces New Website Launch

May 28, 2019

AUSTIN, Texas , May 28, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA ), a clinical-stage biotechnology company, announced today the launch of its newly designed website, www.CassavaSciences.com .  Cassava Sciences’ new website has extensive information on Alzheimer’s disease, a key

View all